Growth Factor Research
6 products · UK stock · Batch certificates · For research use only
Growth factor research compounds
Synthetic peptides studied for their interaction with growth-hormone-releasing hormone (GHRH) receptors and ghrelin receptor signalling pathways in pituitary cell-model research. The category includes GHRH analogues (CJC-1295 with and without DAC, Sermorelin, Tesamorelin) and ghrelin receptor agonists (Ipamorelin, GHRP-6) — researchers use these to compare receptor selectivity, downstream cAMP signalling, and growth hormone release pathway activation in pituitary cell lines.
Supplied batch certificates are published with figures reported per source specifications. Same-day UK dispatch on orders before 2pm via Royal Mail Tracked 24. For in-vitro laboratory research only.
Ipamorelin
Synthetic pentapeptide ghrelin receptor agonist supplied for in-vitro receptor-binding and signalling research.
5mg · Lyophilised · 98%+ purity
CJC-1295 (No DAC)
GHRH analogue fragment — studied for growth hormone secretagogue effects.
5mg · Lyophilised · 98%+ purity
GHRP-6
Growth hormone releasing peptide-6 — classic GH research compound.
5mg · Lyophilised · 98%+ purity
Tesamorelin
Synthetic stabilised GHRH(1-44) analogue supplied for in-vitro GHRH receptor research.
10mg vial · Lyophilised · 98%+ purity
Sermorelin
Synthetic 29-amino-acid analogue of human GHRH supplied for in-vitro GHRH receptor research.
5mg vial · Lyophilised · 98%+ purity
CJC-1295 With DAC
Synthetic GHRH analogue with extended half-life via DAC modification, supplied for in-vitro pituitary research.
5mg vial · Lyophilised · 98%+ purity